amobarbital has been researched along with Child Development Disorders, Pervasive in 1 studies
Amobarbital: A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
amobarbital : A member of the class of barbiturates that is pyrimidine-2,4,6(1H,3H,5H)-trione substituted by a 3-methylbutyl and an ethyl group at position 5. Amobarbital has been shown to exhibit sedative and hypnotic properties.
Child Development Disorders, Pervasive: Severe distortions in the development of many basic psychological functions that are not normal for any stage in development. These distortions are manifested in sustained social impairment, speech abnormalities, and peculiar motor movements.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gallagher, A | 1 |
| Thériault, M | 1 |
| Maclin, E | 1 |
| Low, K | 1 |
| Gratton, G | 1 |
| Fabiani, M | 1 |
| Gagnon, L | 1 |
| Valois, K | 1 |
| Rouleau, I | 1 |
| Sauerwein, HC | 1 |
| Carmant, L | 1 |
| Nguyen, DK | 1 |
| Lortie, A | 1 |
| Lepore, F | 1 |
| Béland, R | 1 |
| Lassonde, M | 1 |
1 other study available for amobarbital and Child Development Disorders, Pervasive
| Article | Year |
|---|---|
Near-infrared spectroscopy as an alternative to the Wada test for language mapping in children, adults and special populations.
Topics: Adolescent; Adult; Aging; Amobarbital; Carotid Arteries; Child; Child Development Disorders, Pervasi | 2007 |